P35637 (FUS_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 149.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: RNA-binding protein FUS Alternative name(s): 75 kDa DNA-pairing protein Oncogene FUS Oncogene TLS POMp75 Translocated in liposarcoma protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 526 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Binds both single-stranded and double-stranded DNA and promotes ATP-independent annealing of complementary single-stranded DNAs and D-loop formation in superhelical double-stranded DNA. May play a role in maintenance of genomic integrity. |
| Subunit structure | Component of nuclear riboprotein complexes. Interacts with ILF3, TDRD3 and SF1. Interacts through its C-terminus with SFRS13A. Interacts with OTUB1 and SARNP. Ref.11 Ref.12 Ref.14 Ref.15 |
| Subcellular location | |
| Tissue specificity | Ubiquitous. |
| Post-translational modification | Arg-216 and Arg-218 are dimethylated, probably to asymmetric dimethylarginine. Ref.13 |
| Involvement in disease | A chromosomal aberration involving FUS is found in a patient with malignant myxoid liposarcoma. Translocation t(12;16)(q13;p11) with DDIT3. A chromosomal aberration involving FUS is a cause of acute myeloid leukemia (AML). Translocation t(16;21)(p11;q22) with ERG. Angiomatoid fibrous histiocytoma (AFH) [MIM:612160]: A distinct variant of malignant fibrous histiocytoma that typically occurs in children and adolescents and is manifest by nodular subcutaneous growth. Characteristic microscopic features include lobulated sheets of histiocyte-like cells intimately associated with areas of hemorrhage and cystic pseudovascular spaces, as well as a striking cuffing of inflammatory cells, mimicking a lymph node metastasis. Amyotrophic lateral sclerosis 6 (ALS6) [MIM:608030]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. Tremor, hereditary essential 4 (ETM4) [MIM:614782]: A common movement disorder mainly characterized by postural tremor of the arms. Head, legs, trunk, voice, jaw, and facial muscles also may be involved. The condition can be aggravated by emotions, hunger, fatigue and temperature extremes, and may cause a functional disability or even incapacitation. Inheritance is autosomal dominant. |
| Sequence similarities | Belongs to the RRM TET family. Contains 1 RanBP2-type zinc finger. Contains 1 RRM (RNA recognition motif) domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| TP63 | Q9H3D4 | 2 | EBI-400434,EBI-2337775 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform Long (identifier: P35637-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform Short (identifier: P35637-2) The sequence of this isoform differs from the canonical sequence as follows: 64-65: TG → S |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 526 | 526 | RNA-binding protein FUS | PRO_0000081591 | ||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||
| Domain | 285 – 371 | 87 | RRM | |||||||||||||||||||||||||||
| Zinc finger | 422 – 453 | 32 | RanBP2-type | |||||||||||||||||||||||||||
| Compositional bias | 1 – 165 | 165 | Gln/Gly/Ser/Tyr-rich | |||||||||||||||||||||||||||
| Compositional bias | 166 – 267 | 102 | Gly-rich | |||||||||||||||||||||||||||
| Compositional bias | 371 – 526 | 156 | Arg/Gly-rich | |||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||
| Site | 175 | 1 | Breakpoint for translocation to form chimeric FUS/ATF1 protein | |||||||||||||||||||||||||||
| Site | 266 – 267 | 2 | Breakpoint for translocation to form FUS/TLS-CHOP oncogene | |||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||
| Modified residue | 221 | 1 | Phosphoserine Ref.18 | |||||||||||||||||||||||||||
| Modified residue | 242 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 244 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 248 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 251 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 259 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 277 | 1 | Phosphoserine Ref.16 | |||||||||||||||||||||||||||
| Modified residue | 286 | 1 | Phosphothreonine Ref.16 | |||||||||||||||||||||||||||
| Modified residue | 377 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 383 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 386 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 388 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 394 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 407 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 473 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 476 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 481 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 485 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 487 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 491 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 495 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 498 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
| Modified residue | 503 | 1 | Asymmetric dimethylarginine Ref.13 | |||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||
| Alternative sequence | 64 – 65 | 2 | TG → S in isoform Short. | VSP_005798 | ||||||||||||||||||||||||||
| Natural variant | 191 | 1 | G → S in ALS6. Ref.23 | VAR_068918 | ||||||||||||||||||||||||||
| Natural variant | 216 | 1 | R → C in ALS6 and ETM4. Ref.23 Ref.25 | VAR_068919 | ||||||||||||||||||||||||||
| Natural variant | 225 | 1 | G → V in ALS6. Ref.23 | VAR_068920 | ||||||||||||||||||||||||||
| Natural variant | 230 | 1 | G → C in ALS6. Ref.23 | VAR_068921 | ||||||||||||||||||||||||||
| Natural variant | 234 | 1 | R → C in ALS6. Ref.23 | VAR_068922 | ||||||||||||||||||||||||||
| Natural variant | 244 | 1 | R → C in ALS6. Ref.21 | VAR_054837 | ||||||||||||||||||||||||||
| Natural variant | 254 | 1 | M → V Found in a patient with frontotemporal lobar degeneration. Ref.24 | VAR_065229 | ||||||||||||||||||||||||||
| Natural variant | 312 | 1 | K → Q in a breast cancer sample; somatic mutation. Ref.20 | VAR_035481 | ||||||||||||||||||||||||||
| Natural variant | 431 | 1 | P → L in ETM4. Ref.25 | VAR_068923 | ||||||||||||||||||||||||||
| Natural variant | 507 | 1 | G → D in ALS6. Ref.23 | VAR_068924 | ||||||||||||||||||||||||||
| Natural variant | 514 | 1 | R → G in ALS6. Ref.22 | VAR_054838 | ||||||||||||||||||||||||||
| Natural variant | 514 | 1 | R → S in ALS6. Ref.21 | VAR_054839 | ||||||||||||||||||||||||||
| Natural variant | 515 | 1 | G → C in ALS6. Ref.21 | VAR_054840 | ||||||||||||||||||||||||||
| Natural variant | 517 | 1 | H → Q Does not affect protein nuclear localization. Ref.21 | VAR_054841 | ||||||||||||||||||||||||||
| Natural variant | 518 | 1 | R → K in ALS6. Ref.21 | VAR_054842 | ||||||||||||||||||||||||||
| Natural variant | 521 | 1 | R → C in ALS6; results in aberrant trafficking and cytoplasmic retention of the protein. Ref.21 Ref.22 Ref.23 | VAR_054843 | ||||||||||||||||||||||||||
| Natural variant | 521 | 1 | R → G in ALS6; results in aberrant trafficking and cytoplasmic retention of the protein. Ref.21 | VAR_054844 | ||||||||||||||||||||||||||
| Natural variant | 521 | 1 | R → H in ALS6; results in aberrant trafficking and cytoplasmic retention of the protein. Ref.21 Ref.22 Ref.24 | VAR_054845 | ||||||||||||||||||||||||||
| Natural variant | 522 | 1 | R → G in ALS6. Ref.21 | VAR_054846 | ||||||||||||||||||||||||||
| Natural variant | 524 | 1 | R → S in ALS6. Ref.21 | VAR_054847 | ||||||||||||||||||||||||||
| Natural variant | 524 | 1 | R → T in ALS6. Ref.21 | VAR_054848 | ||||||||||||||||||||||||||
| Natural variant | 525 | 1 | P → L in ALS6. Ref.21 | VAR_054849 | ||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||
| Sequence conflict | 338 | 1 | T → N AA sequence Ref.7 | |||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||
| Beta strand | 285 – 290 | 6 | ||||||||||||||||||||||||||||
| Helix | 298 – 305 | 8 | ||||||||||||||||||||||||||||
| Turn | 306 – 308 | 3 | ||||||||||||||||||||||||||||
| Turn | 315 – 318 | 4 | ||||||||||||||||||||||||||||
| Beta strand | 319 – 326 | 8 | ||||||||||||||||||||||||||||
| Turn | 328 – 330 | 3 | ||||||||||||||||||||||||||||
| Beta strand | 332 – 343 | 12 | ||||||||||||||||||||||||||||
| Helix | 344 – 354 | 11 | ||||||||||||||||||||||||||||
| Beta strand | 358 – 363 | 6 | ||||||||||||||||||||||||||||
| Beta strand | 365 – 368 | 4 | ||||||||||||||||||||||||||||
| Beta strand | 379 – 381 | 3 | ||||||||||||||||||||||||||||
| Helix | 514 – 521 | 8 | ||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma." Crozat A., Aman P., Mandahl N., Ron D. Nature 363:640-644(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG). |
| [2] | "Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma." Rabbitts T.H., Forster A., Larson R., Nathan P. Nat. Genet. 4:175-180(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT). |
| [3] | "Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes." Morohoshi F., Ootsuka Y., Arai K., Ichikawa H., Mitani S., Munakata N., Ohki M. Gene 221:191-198(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS LONG AND SHORT). |
| [4] | "The sequence and analysis of duplication-rich human chromosome 16." Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J. Pennacchio L.A.Nature 432:988-994(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG). Tissue: Lung and Lymph. |
| [6] | "Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by a chromosomal translocation involving bands 12q13 and 16p11." Waters B.L., Panagopoulos I., Allen E.F. Cancer Genet. Cytogenet. 121:109-116(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 85-310, CHROMOSOMAL TRANSLOCATION WITH ATF1, ASSOCIATION WITH ANGIOMATOID FIBROUS HISTIOCYTOMA. |
| [7] | "Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation." Baechtold H., Kuroda M., Sok J., Ron D., Lopez B.S., Akhmedov A.T. J. Biol. Chem. 274:34337-34342(1999) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 235-244; 307-312; 335-345 AND 349-357, CHARACTERIZATION. |
| [8] | "Human POMp75 is identified as the pro-oncoprotein TLF/FUS: both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferation." Bertrand P., Akhmedov A.T., Delacote F., Durrbach A., Lopez B.S. Oncogene 18:4515-4521(1999) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 265-276; 317-331 AND 335-357, IDENTIFICATION. |
| [9] | Lubec G., Chen W.-Q., Sun Y. Submitted (DEC-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 349-357, MASS SPECTROMETRY. Tissue: Fetal brain cortex. |
| [10] | "An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation." Ichikawa H., Shimizu K., Hayashi Y., Ohki M. Cancer Res. 54:2865-2868(1994) [PubMed] [Europe PMC] [Abstract] Cited for: CHROMOSOMAL TRANSLOCATION. |
| [11] | "The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription." Zhang D., Paley A.J., Childs G. J. Biol. Chem. 273:18086-18091(1998) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SF1. |
| [12] | "Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing." Yang L., Embree L.J., Tsai S., Hickstein D.D. J. Biol. Chem. 273:27761-27764(1998) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SFRS13A. |
| [13] | "Detection of arginine dimethylated peptides by parallel precursor ion scanning mass spectrometry in positive ion mode." Rappsilber J., Friesen W.J., Paushkin S., Dreyfuss G., Mann M. Anal. Chem. 75:3107-3114(2003) [PubMed] [Europe PMC] [Abstract] Cited for: METHYLATION AT ARG-242; ARG-244; ARG-248; ARG-251; ARG-259; ARG-377; ARG-383; ARG-386; ARG-388; ARG-394; ARG-407; ARG-473; ARG-476; ARG-481; ARG-485; ARG-487; ARG-491; ARG-495; ARG-498 AND ARG-503, MASS SPECTROMETRY. |
| [14] | "Intracellular characterization of DDX39, a novel growth-associated RNA helicase." Sugiura T., Sakurai K., Nagano Y. Exp. Cell Res. 313:782-790(2007) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SARNP. |
| [15] | "TDRD3, a novel Tudor domain-containing protein, localizes to cytoplasmic stress granules." Goulet I., Boisvenue S., Mokas S., Mazroui R., Cote J. Hum. Mol. Genet. 17:3055-3074(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TDRD3. |
| [16] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277 AND THR-286, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [17] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [18] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-221, MASS SPECTROMETRY. |
| [19] | "Northeast structural genomics consortium target HR6430A." Northeast structural genomics consortium (NESG) Submitted (MAY-2011) to the PDB data bank Cited for: STRUCTURE BY NMR OF 282-370. |
| [20] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] GLN-312. |
| [21] | "Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis." Kwiatkowski T.J. Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., Valdmanis P., Rouleau G.A., Hosler B.A., Cortelli P., de Jong P.J., Yoshinaga Y., Haines J.L., Pericak-Vance M.A. Brown R.H. Jr.Science 323:1205-1208(2009) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ALS6 CYS-244; SER-514; CYS-515; LYS-518; CYS-521; GLY-521; HIS-521; GLY-522; SER-524; THR-524 AND LEU-525, VARIANT GLN-517, SUBCELLULAR LOCATION, CHARACTERIZATION OF VARIANT ALS6 GLY-521, CHARACTERIZATION OF VARIANT GLN-517. |
| [22] | "Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6." Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J., Williams K.L., Tripathi V., Al-Saraj S., Al-Chalabi A., Leigh P.N., Blair I.P., Nicholson G. Shaw C.E.Science 323:1208-1211(2009) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ALS6 GLY-514; CYS-521 AND HIS-521, SUBCELLULAR LOCATION, CHARACTERIZATION OF VARIANTS ALS6 CYS-521 AND HIS-521. |
| [23] | "Mutations of FUS gene in sporadic amyotrophic lateral sclerosis." Corrado L., Del Bo R., Castellotti B., Ratti A., Cereda C., Penco S., Soraru G., Carlomagno Y., Ghezzi S., Pensato V., Colombrita C., Gagliardi S., Cozzi L., Orsetti V., Mancuso M., Siciliano G., Mazzini L., Comi G.P. Silani V.J. Med. Genet. 47:190-194(2010) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ALS6 SER-191; CYS-216; VAL-225; CYS-230; CYS-234; ASP-507 AND CYS-521. |
| [24] | "Genetic contribution of FUS to frontotemporal lobar degeneration." Van Langenhove T., van der Zee J., Sleegers K., Engelborghs S., Vandenberghe R., Gijselinck I., Van den Broeck M., Mattheijssens M., Peeters K., De Deyn P.P., Cruts M., Van Broeckhoven C. Neurology 74:366-371(2010) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ALS6 HIS-521, VARIANT VAL-254. |
| [25] | "Exome sequencing identifies fus mutations as a cause of essential tremor." Merner N.D., Girard S.L., Catoire H., Bourassa C.V., Belzil V.V., Riviere J.B., Hince P., Levert A., Dionne-Laporte A., Spiegelman D., Noreau A., Diab S., Szuto A., Fournier H., Raelson J., Belouchi M., Panisset M., Cossette P. Rouleau G.A.Am. J. Hum. Genet. 91:313-319(2012) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ETM4 CYS-216 AND LEU-431. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | S62140 mRNA. Translation: AAB27102.1. S62138 mRNA. Translation: AAB27103.1. Sequence problems. X71427 mRNA. Translation: CAA50558.1. Sequence problems. X71428 mRNA. Translation: CAA50559.1. Sequence problems. AF071213 Genomic DNA. Translation: AAC35285.1. AF071213 Genomic DNA. Translation: AAC35284.1. AC009088 Genomic DNA. No translation available. BC000402 mRNA. Translation: AAH00402.1. BC002459 mRNA. Translation: AAH02459.1. AJ295163 mRNA. Translation: CAC15058.1. Different termination. | ||||||||||||||||||||||||
| IPI | IPI00221354. IPI00260715. | ||||||||||||||||||||||||
| PIR | S33798. S33799. | ||||||||||||||||||||||||
| RefSeq | NP_001164105.1. NM_001170634.1. NP_004951.1. NM_004960.3. | ||||||||||||||||||||||||
| UniGene | Hs.46894. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | P35637. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| DIP | DIP-29857N. | ||||||||||||||||||||||||
| IntAct | P35637. 37 interactions. | ||||||||||||||||||||||||
| MINT | MINT-5005976. | ||||||||||||||||||||||||
| STRING | 9606.ENSP00000254108. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | P35637. | ||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||
| DMDM | 544357. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PaxDb | P35637. | ||||||||||||||||||||||||
| PRIDE | P35637. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| DNASU | 2521. | ||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000254108; ENSP00000254108; ENSG00000089280. ENST00000380244; ENSP00000369594; ENSG00000089280. | ||||||||||||||||||||||||
| GeneID | 2521. | ||||||||||||||||||||||||
| KEGG | hsa:2521. | ||||||||||||||||||||||||
| UCSC | uc002ebe.2. human. uc002ebh.3. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 2521. | ||||||||||||||||||||||||
| GeneCards | GC16P031191. | ||||||||||||||||||||||||
| HGNC | HGNC:4010. FUS. | ||||||||||||||||||||||||
| HPA | CAB033036. CAB058691. HPA008784. | ||||||||||||||||||||||||
| MIM | 137070. gene. 608030. phenotype. 612160. phenotype. 614782. phenotype. | ||||||||||||||||||||||||
| neXtProt | NX_P35637. | ||||||||||||||||||||||||
| Orphanet | 803. Amyotrophic lateral sclerosis. 275872. Frontotemporal dementia with motor neuron disease. 79105. Myxofibrosarcoma. 99967. Myxoid liposarcoma. | ||||||||||||||||||||||||
| PharmGKB | PA28425. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | NOG240581. | ||||||||||||||||||||||||
| HOGENOM | HOG000038010. | ||||||||||||||||||||||||
| HOVERGEN | HBG095056. | ||||||||||||||||||||||||
| InParanoid | P35637. | ||||||||||||||||||||||||
| KO | K13098. | ||||||||||||||||||||||||
| OMA | YGTQSTP. | ||||||||||||||||||||||||
| OrthoDB | EOG4DV5NH. | ||||||||||||||||||||||||
| PhylomeDB | P35637. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Reactome | REACT_1675. mRNA Processing. REACT_71. Gene Expression. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | P35637. | ||||||||||||||||||||||||
| Bgee | P35637. | ||||||||||||||||||||||||
| CleanEx | HS_FUS. | ||||||||||||||||||||||||
| Genevestigator | P35637. | ||||||||||||||||||||||||
| GermOnline | ENSG00000089280. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| Gene3D | 3.30.70.330. 1 hit. | ||||||||||||||||||||||||
| InterPro | IPR012677. Nucleotide-bd_a/b_plait. IPR000504. RRM_dom. IPR001876. Znf_RanBP2. [Graphical view] | ||||||||||||||||||||||||
| Pfam | PF00076. RRM_1. 1 hit. PF00641. zf-RanBP. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| SMART | SM00360. RRM. 1 hit. SM00547. ZnF_RBZ. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PROSITE | PS50102. RRM. 1 hit. PS01358. ZF_RANBP2_1. 1 hit. PS50199. ZF_RANBP2_2. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| ChiTaRS | FUS. human. | ||||||||||||||||||||||||
| GenomeRNAi | 2521. | ||||||||||||||||||||||||
| NextBio | 9927. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | FUS_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P35637 Secondary accession number(s): Q9H4A8 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
